Clinical trial

Hydroxychloroquine and Gefitinib to Treat Lung Cancer

NCT00809237

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2013-12-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

Gefitinib, HydroxychloroquineDRUG

Sponsors & collaborators

National University Hospital, Singaporelead sponsor

Massachusetts General Hospitalcollaborator

AstraZenecacollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00809237 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.